Creating winning pharma communications
Season 03: episode 12
This week, the GOLD team catches up with Silvia Taylor, Executive Vice President and Chief Communications Officer, Novavax.
Silvia discusses her passion for engaging the world in the wonder of science, her concerns and solutions around vaccine access and hesitancy, the advice she would give her younger self on how to succeed, and much more.
Meanwhile, in news you might’ve missed, Helena and Isabel discuss a new ABPI report detailing how pharma can improve its impact on the environment, as well as the Access to Medicine Foundation’s newly-launched 2022 Access to Medicine Index.
A little more on GOLD’s guest…
Silvia Taylor is Executive Vice President and Chief Communications Officer, Novavax. Here, she oversees investor relations, public relations, external and internal communications, corporate social responsibility and ESG strategy, digital and social media and meetings, events and corporate merchandising for the company. She also has more than 25 years of communications and commercial leadership experience, having held positions at MedImmune LLC – the global biologics arm of AstraZeneca – and Pfizer earlier in her career. In 2022, she was elected to the Page Society, a membership organisation of Chief Communications Officers of Fortune Global 500 corporations.
If you’re interested in learning more about the topic areas discussed in this episode, check out the following content:
Click here to subscribe to the weekly newsletter for more insights from GOLD.